State of Tennessee, Department of Treasury’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$987K Buy
+79,395
New +$1.07M ﹤0.01% 1203
2025
Q3
Sell
-16,397
Closed -$133K 1733
2025
Q2
$133K Buy
+16,397
New +$124K ﹤0.01% 1674
2023
Q1
Sell
-104,193
Closed -$207K 1654
2022
Q4
$207K Buy
+104,193
New +$234K ﹤0.01% 1521
2022
Q3
Sell
-87,871
Closed -$279K 1647
2022
Q2
$279K Sell
87,871
-9,349
-10% -$33.9K ﹤0.01% 1477
2022
Q1
$405K Buy
97,220
+32,647
+51% +$145K ﹤0.01% 1455
2021
Q4
$309K Hold
64,573
﹤0.01% 1500
2021
Q3
$345K Sell
64,573
-3,260
-5% -$16.4K ﹤0.01% 1462
2021
Q2
$347K Buy
67,833
+12,809
+23% +$72.8K ﹤0.01% 1464
2021
Q1
$370K Buy
55,024
+26,380
+92% +$146K ﹤0.01% 1401
2020
Q4
$131K Buy
+28,644
New +$127K ﹤0.01% 1532

Other funds holding AMRX

State of Tennessee, Department of Treasury's AMRX Position: Q1 2026 in Review

State of Tennessee, Department of Treasury opened a new position in Amneal Pharmaceuticals (AMRX) in Q1 2026: 79,395 shares worth $987K. The stake represents ﹤0.01% of the portfolio and ranks #1203 among its holdings. This is a return to the name: State of Tennessee, Department of Treasury previously reported a position in AMRX as recently as Q2 2025.

State of Tennessee, Department of Treasury first reported a position in AMRX in Q4 2020 and has held it in 10 quarters since. 316 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.

  • State of Tennessee, Department of Treasury held 79,395 shares of Amneal Pharmaceuticals worth $987K as of Q1 2026.
  • Amneal Pharmaceuticals was a new State of Tennessee, Department of Treasury position in Q1 2026.
  • Amneal Pharmaceuticals made up ﹤0.01% of State of Tennessee, Department of Treasury's portfolio in Q1 2026, its #1203 holding.
  • State of Tennessee, Department of Treasury first reported a position in Amneal Pharmaceuticals in Q4 2020 and has held it in 10 quarters since.
  • 316 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.

Based on State of Tennessee, Department of Treasury's 13F filing for Q1 2026, filed 15 May 2026.